Fritextsökning
Innehållstyper
-
Studie: AI ger mer exakt bröstcancerdiagnostik
Forskare vid Karolinska institutet har utvecklat en metod för vävnadsanalys som med hjälp av AI kan ge en mer precis diagnos vid bröstcancer. Därmed ökar möjlig...
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Danisco strengthens its IP team
Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.
-
New firm based on SLU research
Four researchers at the Swedish University of Agricultural Sciences, SLU, has recently founded a new nanotech company.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Bring talent to those in need
Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.
-
Otto Cars får pris
Otto Cars prisas med APUA Leadership Award för sitt engagemang för att förebygga antibiotikaresistens.
-
Han tar över på Elekta
Gustaf Salford är ny vd och koncernchef för bolaget.
-
ATMP-expert till Eliceras styrelse
Karin Hoogendoorn har valts in i styrelsen för Elicera Therapeutics.
-
Biogaia's advance goes on
In December Biogaia reached China and North America. Now, the Swedish probiotic company has entered the Mexican market.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Life science möter digitalt i nytt samarbete
Astrazeneca Bioventure Hub och IBM Sverige möts i nytt life science-digitalt samarbete – "Många av företagen befinner sig i gränslandet mellan pharma och IT"
-
Anna Nilsson Vindefjärd om upptäckten som bör få Nobelpriset
Favoriten till årets Nobelpris för Anna Nilsson Vindefjärd, Forska Sverige, är en teknik som fått avgörande betydelse under pandemin, men som också används till...
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Ny Nordamerikachef hos Calliditas
Andrew Udell har utsetts till ny chef för Calliditas Therapeutics verksamhet i Nordamerika.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Hon tar plats i Senzimes styrelse
Olinks marknadsdirektör är ny ledamot i Senzimes styrelse.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.